AirXpanders Inc logo

AXP - AirXpanders Inc Share Price

A$0.035 0.0  0.0%

Last Trade - 27/03/19

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £5.93m
Position in Universe th / 1832
Bullish
Bearish
Unlock AXP Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

AXP Revenue Unlock AXP Revenue

Net Income

AXP Net Income Unlock AXP Revenue

Normalised EPS

AXP Normalised EPS Unlock AXP Revenue

PE Ratio Range

AXP PE Ratio Range Unlock AXP Revenue

Dividend Yield Range

AXP Dividend Yield Range Unlock AXP Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
AXP EPS Forecasts Unlock AXP Revenue
Profile Summary

AirXpanders, Inc. (AirXpanders) is a medical device company. The Company is engaged in developing initial product technology, recruiting personnel and raising capital. AirXpanders focuses on the field of tissue expansion after mastectomy, with an emphasis on breast reconstruction. The Company is designing the AeroForm patient controlled tissue expander. The AeroForm system consists of a self-contained expander (which is implanted in a similar manner to traditional saline expanders following a mastectomy), and a small hand-held wireless remote control unit. The lipstick-sized carbon dioxide (CO2) reservoir in the expander gradually releases a predetermined amount of CO2 through a small internal valve, eliminating the need for frequent saline injections at doctors' offices typically associated with on-market expanders.

Directors
Last Annual December 31st, 2018
Last Interim March 31st, 2019
Incorporated March 17, 2005
No. of Shareholders: 2,001
No. of Employees: 70
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange Australian Stock Exchange - SEATS
Shares in Issue 558,459,855
Free Float (0.0%)
Eligible for
ISAs
SIPPs
AXP Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Similar to AXP
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.